期刊文献+

结直肠肿瘤组织miR-215表达及临床意义 被引量:3

THE EXPRESSION OF MIR-215 IN COLORECTAL NEOPLASMS AND ITS CLINICAL SIGNIFICANCE
下载PDF
导出
摘要 目的研究microRNA-215(miR-215)在结直肠肿瘤组织和病人血清中的表达水平及其临床意义。方法从结直肠癌、结直肠腺瘤病人病变组织及健康查体者(正常对照组)结直肠组织和血清标本中提取微小RNA(microRNA),应用实时荧光定量PCR(RT-qPCR)方法检测miR-215的表达,分析miR-215表达水平与结直肠肿瘤临床病理参数间的关系,并通过绘制受试者工作曲线(ROC曲线)探讨血清miR-215在结直肠肿瘤诊断中的价值。结果与正常对照组比较,miR-215在结直肠癌和结直肠腺瘤病变组织中表达显著降低,差异有显著性(F=16.603,t=5.756、3.572,P〈0.01);miR-215在结直肠癌和结直肠腺瘤病人血清中的表达也低于正常对照组,差异有显著性(F=27.329,t=7.377、4.691,P〈0.01);与结直肠腺瘤组相比,结直肠癌组miR-215表达下调(t=2.182、2.671,P〈0.05)。结直肠癌组织和病人血清中miR-215的低表达与病人的临床分期有关(F=4.073、6.125,P〈0.05),且结直肠癌组织与血清中miR-215的表达量呈正相关(r=0.696,P〈0.01);miR-215表达与结直肠腺瘤临床特征无关(P〉0.05)。ROC曲线分析显示,结直肠癌和正常对照组血清miR-215的ROC曲线下面积(AUC)为0.855(95%CI=0.740~0.970),结直肠腺瘤与正常对照组血清miR-215的AUC为0.774(95%CI=0.634~0.913)。结论 miR-215在结直肠癌的早期诊断中具有潜在的价值。 Objective To explore miR-215 expression in tumor tissues and in serum in patients with colorectal neoplasms and its clinical significance. Methods MicroRNA was extracted from tissues of colorectal cancer,colorectal adenoma and healthy individuals who came for medical examination.The expression of miR-215 was detected using quantitative real-time polymerase chain reaction(RT-qPCR).The relationship between the level of miR-215 expression and clinicopathological parameters in colorectal neoplasms was analyzed,and the value of serum miR-215 in the diagnosis of colorectal tumors was evaluated through drawing a receiver operating characteristic(ROC)curve. Results Compared with normal controls,the expression of miR-215 in tissues of colorectal cancer and colorectal adenoma was lower(F=16.603;t=5.756,3.572;P〈0.01),and that in serum was also lower(F=27.329;t=7.377,4.691;P〈0.01).Compared with colorectal adenoma,the expression of miR-215 in colorectal cancer was downregulated(t=2.182,2.671;P〈0.05).Low expression of miR-215 in cancer tissue and serum was associated with clinical stage of the disease(F=4.073,6.125;P〈0.05),and the expression of miR-215 in cancer was positively correlated with that in serum(r=0.696,P〈0.01),but the expression of miR-215 was not correlated with clinical features of colorectal adenoma(P〉0.05).ROC curve analysis demonstrated that the area under the ROC curve of serum miR-215 in the cancer and normal control group was 0.855(95%CI=0.740-0.970)and that in the adenoma and normal control was 0.774(95%CI=0.634-0.913). Conclusion There is a potential value of miR-215 in early diagnosis of colorectal cancer.
出处 《齐鲁医学杂志》 2015年第6期631-634,共4页 Medical Journal of Qilu
关键词 结直肠肿瘤 聚合酶链反应 组织 血清 微RNAS colorectal neoplasms polymerase chain reaction tissue serum micrornas
  • 相关文献

参考文献16

  • 1CUNNINGHAM D, ATKIN W, LENZ H J, et al. Colorectal cancer[J]. Lancet, 2010,375(9719):1030 1047.
  • 2TANG F C. Small RNAs in mammalian germline: tiny for im mortaI[J]. Differentiation: Research in Biological Diversity, 2010,79 (3) : 141-146.
  • 3XIONG Y, ZHANG Y Y, WU Y Y, et al. Correlation of over expressions of miR-21 and Notch 1 in human colorectal cancer with clinical stages[J]. Life Sciences, 2014,106(1/2) 19-24.
  • 4HUANG Z H, HUANG D, NI S J, et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer[J]. International Journal of Cancer. Journal Interna- tional du Cancer, 2010,127(1) :118-126.
  • 5BRAUN C J, ZHANG X, SAVELYEVA I, et al. p53-Re- sponsive microRNAs 192 and 215 are capable of inducing cell cycle arrest[J]. Cancer Research, 2008,68(24) :10094-10104.
  • 6CHIANG Y, ZHOU X, WANG Z N, et al. Expression levels of microRNA-192 and 215 in gastric carcinoma[J]. Pathology Oncology Research: POR, 2012,18(3) : 585-591.
  • 7WHITE N M, KHELLA H W, GRIGULL J, et al. miRNA profiling in metastatic renal cell carcinoma reveals a tumou: suppressor effect for miR-215[J]. British Journal of Cancer, 2011,105(11) :1741-1749.
  • 8王虹,吴琍,侯琳,崔文,陈庆峰,胡海燕.家族性乳癌病人乳癌组织及血清miRNA-26a、143与195表达及意义[J].齐鲁医学杂志,2015,30(4):379-382. 被引量:1
  • 9张腾龙,张鹏,孟月生,邢秀华.多发性骨髓瘤组织微小RNA-19表达及其临床意义[J].齐鲁医学杂志,2013,28(1):14-16. 被引量:4
  • 10ZHAI H Y, JU J F. Implications of microRNAs in coloreetal cancer development, diagnosis, prognosis, and therapeutics [J]. Frontiers in Genetics, 2011,2(78):1-11.

二级参考文献43

  • 1TURNER M L, SCHNORFEIL F M, BROCKER T. Micro- RNAs regulate dendritic cell differentiation and function[J]. J Immunol, 2011,187(8):3911.
  • 2SAYED I), ABI)EI.LATIF M. MicroRNAs in development and disease[J]. Physiol Rev, 2011,91(3):827-887.
  • 3ESQUELA-KERSCHER A, SLACK F J. Oncomirs-micro RNAs witha role in cancer[J].Nat RevCancer, 2006,6(4): 259 269.
  • 4ZHANG W, DAHLBERG J E, TAM W. Micro-RNAs in tu-- morigenesis:A primer[J]. Am J Pathol, 2007,171 (3):728-738.
  • 5TODOERTI K, BARBUI V, PEDR1NI O, et al. Pleiotropic anti myeloma activity of ITF2357: inhibition of interleukin-6 receptor signaling and repression of miRNA 19a and miRNA 19b[J]. Haematologica, 2010,95(2):260-269.
  • 6PICHIORRI F, SUH SS, LADETTO M, ct al. MicroRNAs regulate critical genes associated with multiple myeloma patho- genesis [J].Proc Natl Acad Sci USA, 200,105(35):12885.
  • 7SCHMITTGEN T D, I.IVAK K J. AnaLyzing real-time PCR data by the comparativeC (T) method[J]. Nat Protoc, 2008, 3(6) : 1101-1108.
  • 8MAVRAKIS K J, WOLFE A L, OR1CCHIO E, et al. Ge- nome-wide RNA-mediated interference screen identifies miRNA 19 targets in Notch induced T cell acute'lymphoblastic leukae mia[J].Nat Cell Biol, 2010,12(4) :372-379.
  • 9ZHANGX, YUH, LOUJ R, etal. MicroRNA-19 (miRNA- 19) regulates tissue factor expression in breast cancer cells[J].J Biol Chem, 2011,286(2):1429-1435.
  • 10OLIVEV, BENNETTMJ, WALKER J C, etal. miRNA-19 is a key oncogenic component of miRNA 17 92[J].Genes Dev, 2009,23(24) :2839-2849.

共引文献5

同被引文献46

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部